We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+12.93%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$527M
AUM Growth
-$27.8M
Cap. Flow
-$55.3M
Cap. Flow %
-10.5%
Top 10 Hldgs %
7.71%
Holding
433
New
128
Increased
66
Reduced
125
Closed
114

Top Buys

Rank Stock Value
1
MODV
ModivCare
MODV
+$3.1M
2
BBW icon
Build-A-Bear
BBW
+$2.62M
3
MXWL
Maxwell Technologies Inc
MXWL
+$2.54M
4
CTRN icon
Citi Trends
CTRN
+$2.52M
5
RDNT icon
RadNet
RDNT
+$2.46M

Sector Composition

Rank Sector Weight
1 Healthcare 19.04%
2 Industrials 15.39%
3 Technology 15.29%
4 Consumer Discretionary 10.27%
5 Energy 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTCT icon
26
PTC Therapeutics
PTCT
$6.25B
$2.86M 0.54%
+109,344
New +$2.34M
RDNT icon
27
RadNet
RDNT
$4.97B
$2.84M 0.54%
+427,897
New +$2.46M
ENTA icon
28
Enanta Pharmaceuticals
ENTA
$367M
$2.78M 0.53%
64,554
-1,292
-2% -$49.3K
PAMT
29
PAMT Corp
PAMT
$360M
$2.76M 0.52%
395,464
-4,012
-1% -$24.3K
HEES
30
DELISTED
H&E Equipment Services
HEES
$2.7M 0.51%
74,268
-8,284
-10% -$304K
BBW icon
31
Build-A-Bear
BBW
$443M
$2.69M 0.51%
+200,964
New +$2.62M
POZN
32
DELISTED
POZEN INC
POZN
$2.67M 0.51%
319,948
-17,081
-5% -$147K
ACTA
33
DELISTED
Actua Corp
ACTA
$2.61M 0.5%
124,991
-12,547
-9% -$250K
KERX
34
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$2.59M 0.49%
168,513
-62,271
-27% -$883K
HZNP
35
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.58M 0.49%
163,324
-138,410
-46% -$1.98M
OMER icon
36
Omeros
OMER
$816M
$2.58M 0.49%
+148,442
New +$1.87M
SXI icon
37
Standex International
SXI
$3.56B
$2.53M 0.48%
+33,977
New +$2.33M
SYNA icon
38
Synaptics
SYNA
$4.33B
$2.52M 0.48%
27,850
-2,806
-9% -$190K
BFX
39
DELISTED
BowFlex Inc.
BFX
$2.47M 0.47%
+222,677
New +$2.26M
STAA icon
40
STAAR Surgical
STAA
$1.13B
$2.47M 0.47%
146,860
-14,865
-9% -$245K
PSIX
41
Power Solutions International
PSIX
$643M
$2.45M 0.46%
34,039
-2,716
-7% -$209K
MXWL
42
DELISTED
Maxwell Technologies Inc
MXWL
$2.45M 0.46%
+161,863
New +$2.54M
SRGA
43
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$2.42M 0.46%
+18,507
New +$2.35M
ACIC icon
44
American Coastal Insurance
ACIC
$526M
$2.35M 0.45%
136,056
-19,710
-13% -$321K
SUNE
45
DELISTED
SUNEDISON, INC COM
SUNE
$2.33M 0.44%
103,231
+6,168
+6% +$120K
ATRC icon
46
AtriCure
ATRC
$2.01B
$2.33M 0.44%
126,554
-39,777
-24% -$662K
NVAX icon
47
Novavax
NVAX
$1.21B
$2.3M 0.44%
24,940
-2,733
-10% -$240K
INSM icon
48
Insmed
INSM
$22.6B
$2.26M 0.43%
113,017
-191,005
-63% -$2.83M
CVLG icon
49
Covenant Logistics
CVLG
$1.09B
$2.21M 0.42%
343,884
-3,512
-1% -$18.8K
SN
50
DELISTED
Sanchez Energy Corporation
SN
$2.17M 0.41%
57,677
+11,880
+26% +$375K

Similar funds

EAM Investors's Q2 2014 Portfolio in Review

As of Q2 2014, EAM Investors held 433 positions worth $527M, down 5% from $555M the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

EAM Investors withdrew a net $55.3M in Q2 2014, closing 114 positions and reducing 125 holdings. Its most notable exit was CalAmp Corp., an estimated $4.65M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Industrials and Technology.

Against the trend, EAM Investors opened a new position in ModivCare worth $2.88M.

  • EAM Investors's largest Q2 2014 buy was ModivCare: 78,620 shares worth $2.88M.
  • EAM Investors added most to Intevac Inc in Q2 2014, an estimated $1.18M increase.
  • EAM Investors's biggest Q2 2014 reduction was Ceco Environmental, cutting an estimated $2.88M.
  • EAM Investors fully exited CalAmp Corp. in Q2 2014, selling an estimated $4.65M.
  • EAM Investors's ten largest holdings make up 7.7% of its $527M portfolio in Q2 2014.
  • EAM Investors opened 128 new positions and closed 114 in Q2 2014.
  • EAM Investors's portfolio value fell 5% quarter-over-quarter to $527M.

Based on EAM Investors's 13F filing for Q2 2014, filed 11 Aug 2014.